Drug Abuse Testing Market by Product Type, Distribution Channel, End User 2023-2028

1
Global Drug Abuse Testing Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Drug Abuse Testing Market Research
Report The latest report by IMARC, titled Drug
Abuse Testing Market Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2023-2028 finds that the global drug abuse
testing market size reached US 6.6 Billion in
2022. A drug abuse test is a non-invasive
analysis of biological samples, including blood,
hair, and urine, to detect the presence of
illegal, prescription drugs or their metabolites.
Drug abuse is the intentional use of illegal
substances or the excessive use of
over-the-counter (OTC) medications and prescribed
psychoactive or performance-enhancing substances.
Drug abuse testing helps identify infants and
children at risk of exposure to illegal drugs and
manage cases of acute mental state and seizure in
the emergency room. Currently, it finds extensive
applications in sports organizations, employers,
and forensic purposes across the globe. Request
Free Sample Report https//www.imarcgroup.com/dru
g-abuse-testing-market/requestsample
4
Report Description and Highlights
Report Description

Global Drug Abuse Testing Market Trends The
rising drug production and consumption represents
the primary factor driving the market growth.
Additionally, the increasing number of
individuals consuming alcohol and illicit drugs,
such as marijuana, cocaine, and opioids, is
positively influencing market growth. Moreover,
drugs such as opiates, cannabinoids, cocaine,
alcohol, diazepam, lysergic acid diethylamide
(LSD), barbiturates, amphetamines, and ketamine
are abused for their psychological impact,
non-therapeutic and medicinal uses, along with
other purposes, such as weight loss and enhancing
athletic performance. In line with this, the
rising drug dependence and substance use disorder
has catalyzed market growth. Besides this, drug
abuse can pose severe risks to health and safety
and lower the morale and productivity of
individuals. As a result, the escalating demand
for drug abuse testing for employee and job
applicant screening to ensure a safe workplace is
propelling the market growth. Apart from this,
the rising demand for urine drug testing due to
rapid expansion in pain management and opioid
dependency clinics is another major
growth-inducing factor. Furthermore, several key
players are launching automated testing and
analysis for drug abuse and at-home use kits for
instant drug abuse tests, thereby contributing to
the market growth. Other factors, including
increasing mortality due to drugs, the emerging
e-commerce industry, technological advancements
in drug screening or testing devices, and
stringent government policies mandating drug
screening, are also creating a favorable market
outlook. Looking forward, IMARC Group expects the
market value to reach US 9.8 Billion by 2028,
expanding at a CAGR of 6.9 during
2023-2028. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Product Ana
lyzers Immunoassays Analyzers
Chromatographic Devices
Breath Analyzers
Rapid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables Laboratory Service
s Breakup by Sample Urine Or
al Fluid (Saliva) Hair Breath
Others

6
Report Description and Highlights
Report Description
Breakup by End User Hospitals
Diagnostic Laboratories Forensic Labora
tories Workplaces Others Brea
kup by Region North America
United States Canada
Asia-Pacific China
Japan India
South Korea Australia
Indonesia Other
s Europe

7
Report Description and Highlights
Report Description
Germany France
United Kingdom
Italy Spain
Russia Others Latin Am
erica Brazil M
exico Others Middle Ea
st and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Abbott Laboratories Bio-Rad Laboratories Inc. Dana
  her Corporation Drägerwerk AG Co. KGaA F. Hoffma
  nn-La Roche AG Laboratory Corporation of America H
  oldings Omega Laboratories Inc. Quest Diagnostics
  Incorporated Siemens AG Thermo Fisher Scientific I
  nc. United States Drug Testing Laboratories Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/drug-abuse-testing-mark
  et

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us